{"entity":{"type":"insider","cik":"0001875786","url":"/insider/0001875786","json_url":"/insider/0001875786.json","name":"Auster Martin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":8,"first":"2022-12-06","last":"2024-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Auster Martin","source":"filing","n_filings":8,"first_seen":"2022-12-06","last_seen":"2024-04-03"}],"transactions":[{"id":2329532,"accession":"0001415889-24-010177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010177","line_url":"/filing/0001415889-24-010177#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":5.4035,"price_display":"5.40","price_state":"stated","total_value":7591.9175,"total_display":"7,591.92","shares_owned_after":24303.0,"shares_owned_after_display":"24,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":8680883,"accession":"0001209191-23-048632","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-048632","line_url":"/filing/0001209191-23-048632#line-3","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18327.0,"shares_display":"18,327","price_per_share":32.2575,"price_display":"32.26","price_state":"stated","total_value":591183.2025,"total_display":"591,183.20","shares_owned_after":29322.0,"shares_owned_after_display":"29,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":8680879,"accession":"0001209191-23-048632","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-048632","line_url":"/filing/0001209191-23-048632#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8142.0,"shares_display":"8,142","price_per_share":33.413,"price_display":"33.41","price_state":"stated","total_value":272048.646,"total_display":"272,048.65","shares_owned_after":21180.0,"shares_owned_after_display":"21,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":8680873,"accession":"0001209191-23-048632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048632","line_url":"/filing/0001209191-23-048632#line-1","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":33.9796,"price_display":"33.98","price_state":"stated","total_value":101.9388,"total_display":"101.94","shares_owned_after":21177.0,"shares_owned_after_display":"21,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":7898710,"accession":"0001209191-23-043460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043460","line_url":"/filing/0001209191-23-043460#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":35.5373,"price_display":"35.54","price_state":"stated","total_value":995044.4,"total_display":"995,044.40","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-26","scope":"insider"},{"id":8112705,"accession":"0001209191-23-035224","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-035224","line_url":"/filing/0001209191-23-035224#line-3","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24246.0,"shares_display":"24,246","price_per_share":34.5945,"price_display":"34.59","price_state":"stated","total_value":838778.247,"total_display":"838,778.25","shares_owned_after":51403.0,"shares_owned_after_display":"51,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8112701,"accession":"0001209191-23-035224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035224","line_url":"/filing/0001209191-23-035224#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3754.0,"shares_display":"3,754","price_per_share":34.9452,"price_display":"34.95","price_state":"stated","total_value":131184.2808,"total_display":"131,184.28","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8393657,"accession":"0001209191-23-025876","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-025876","line_url":"/filing/0001209191-23-025876#line-4","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18748.0,"shares_display":"18,748","price_per_share":37.554,"price_display":"37.55","price_state":"stated","total_value":704062.392,"total_display":"704,062.39","shares_owned_after":56901.0,"shares_owned_after_display":"56,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-27","scope":"insider"},{"id":8393653,"accession":"0001209191-23-025876","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-025876","line_url":"/filing/0001209191-23-025876#line-3","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4990.0,"shares_display":"4,990","price_per_share":39.229,"price_display":"39.23","price_state":"stated","total_value":195752.71,"total_display":"195,752.71","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-27","scope":"insider"},{"id":8393649,"accession":"0001209191-23-025876","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-025876","line_url":"/filing/0001209191-23-025876#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4262.0,"shares_display":"4,262","price_per_share":38.7553,"price_display":"38.76","price_state":"stated","total_value":165175.0886,"total_display":"165,175.09","shares_owned_after":52639.0,"shares_owned_after_display":"52,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-27","scope":"insider"},{"id":8220002,"accession":"0001209191-23-024854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024854","line_url":"/filing/0001209191-23-024854#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":33.0019,"price_display":"33.00","price_state":"stated","total_value":231013.3,"total_display":"231,013.30","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":8723356,"accession":"0001209191-23-023474","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-023474","line_url":"/filing/0001209191-23-023474#line-4","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9577.0,"shares_display":"9,577","price_per_share":30.2431,"price_display":"30.24","price_state":"stated","total_value":289638.1687,"total_display":"289,638.17","shares_owned_after":59072.0,"shares_owned_after_display":"59,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8723354,"accession":"0001209191-23-023474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-023474","line_url":"/filing/0001209191-23-023474#line-3","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9535.0,"shares_display":"9,535","price_per_share":31.069,"price_display":"31.07","price_state":"stated","total_value":296242.915,"total_display":"296,242.92","shares_owned_after":49537.0,"shares_owned_after_display":"49,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8723352,"accession":"0001209191-23-023474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023474","line_url":"/filing/0001209191-23-023474#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1888.0,"shares_display":"1,888","price_per_share":31.861,"price_display":"31.86","price_state":"stated","total_value":60153.568,"total_display":"60,153.57","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":6386737,"accession":"0000899243-22-037793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-037793","line_url":"/filing/0000899243-22-037793#line-2","is_derivative":false,"issuer_cik":"0001851194","issuer_name":"Ventyx Biosciences, Inc.","issuer_ticker":"VTYX","issuer_name_source":null,"issuer_url":"/issuer/0001851194","owner_cik":"0001875786","owner_name":"Auster Martin","owner_url":"/insider/0001875786","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97647.0,"shares_display":"97,647","price_per_share":29.0086,"price_display":"29.01","price_state":"stated","total_value":2832602.7642,"total_display":"2,832,602.76","shares_owned_after":47649.0,"shares_owned_after_display":"47,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001851194","name":"Ventyx Biosciences, Inc.","url":"/issuer/0001851194","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":8,"first_seen":"2022-12-06","last_seen":"2024-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001875786","retrieved_at":"2026-08-22T04:01:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}